Repression of gene transcription is a fundamental property of nuclear hormone receptors. We report here that cell-specific repression by nuclear receptors correlates with levels of nuclear receptor corepressor (N-CoR) protein. N-CoR protein levels are regulated by mSiah2, a mammalian homolog of Drosophila Seven in absentia that targets N-CoR for proteasomal degradation. mSiah2 expression is cell-type specific and differentially regulates the repressive activities of nuclear receptors. These findings establish targeted proteolysis of transcriptional coregulators as a mechanism for cell-specific regulation of gene transcription.
Nuclear hormone receptors are among the best studied transcriptional repressors (Mangelsdorf et al. 1995; Shibata et al. 1997b) . Thyroid hormone receptor (TR) and retinoic acid receptors (RAR) repress transcription in the absence of ligand, thus amplifying the magnitude of ligand-induced activation (Graupner et al. 1989; Baniahmad et al. 1992) . Orphan members of the nuclear receptor superfamily, such as RevErb and COUP-TF, are ligand-independent repressors of transcription (Harding and Lazar 1995; Shibata et al. 1997a ). RevErb does not possess the carboxy-terminal amphipathic helix characteristic of ligand-activated receptors, and thus its main function is to constitutively repress transcription. This is likely to serve major developmental roles in a number of organisms; RevErb antagonizes the effects of ROR␣, whose mutation leads to the cerebellar degeneration of the Staggerer mouse (Hamilton et al. 1996) . In Drosophila, the RevErb homolog E75 regulates metamorphosis (Segraves and Hogness 1990; White et al. 1997) .
Corepressors N-CoR (nuclear receptor corepressor) and SMRT (silencing mediator of retinoid and thyroid receptors) bind to nuclear receptor dimers and serve as a scaffold for additional proteins involved in repression, including Sin3 and histone deacetylases (Chen and Evans 1995; Horlein et al. 1995; Alland et al. 1997; Hassig et al. 1997; Heinzel et al. 1997; Nagy et al. 1997) . Receptor specificity of corepressor interaction on DNA is exemplified by the observation that RevErb specifically utilizes N-CoR, whereas thyroid hormone receptor TR may use both SMRT and N-CoR to mediate repression (Zamir et al. 1997b) .
The amino terminus of N-CoR contains two repression domains that have not been identified in the reported sequence of SMRT (Chen and Evans 1995) . However, the function of the amino terminus of N-CoR has not been well characterized. Here we show that the extreme amino terminus of N-CoR targets the protein for proteasomal degradation because of interaction with mSiah2, the mammalian homolog of Drosophila Seven in absentia (sina). This results in a receptor-specific antirepression function for mSiah2. Expression of mSiah2 is cell-type specific, explaining the cell specificity of repression by RevErb.
Results and Discussion

N-CoR interacts with mSiah2
To test the hypothesis that the unique amino terminus of N-CoR has a regulatory function, amino acids 1-160 were used as bait in a yeast dihybrid screen of a 17-day mouse embryo library. Eleven positive clones were identical to mSiah2, a homolog of sina (Carthew and Rubin 1990) . The clones (mSiah2⌬N) began at amino acid 108 of the full-length mSiah2 protein (Fig. 1A) . Polypeptides containing N-CoR amino acids 1-160 interacted with mSiah2 in yeast, whereas other regions of the amino terminus of N-CoR as well as that of SMRT did not (Fig.  1B) . The in vivo interaction in yeast was recapitulated in vitro, as a GST fusion of N-CoR interacted with in vitrotranslated mSiah2 (Fig. 1C) . Although N-CoR amino acids 1-312 interacted with both mSiah2 and mSin3B, amino acids 1-160 of N-CoR interacted strongly with mSiah2 but not with mSin3B. N-CoR (1-312) also interacted strongly with Sina, whereas the amino terminal repression domain of SMRT did not (Fig. 1D ). The ability of N-CoR to interact with mSiah2 was also observed in mammalian cells. Consistent with an in vivo interaction, transfected HA-tagged mSiah2⌬N coimmunoprecipitated with endogenous N-CoR in 293T cells (Fig. 1E ). As this interaction might have occurred in vitro during processing of the cells, we also tested for in vivo interaction using a mammalian two-hybrid assay. Figure 1F shows that Gal4-N-CoR(1-160) but not Gal4-SMRT(1-483) was activated by VP16-mSiah2⌬N, consistent with in vivo interaction between N-CoR and mSiah2.
mSiah2 targets N-CoR for proteolytic degradation
Both Sina and mSiah2 have been implicated in regulating proteasomal degradation of certain proteins to which they bind (Hu et al. 1997; Li et al. 1997; Tang et al. 1997) . Transfection of mSiah2 with N-CoR in 293T cells led to [Key Words: Nuclear receptor corepressor; proteasomal regulation; repression; RevErb; thyroid hormone receptor; cell specificity] near complete loss of N-CoR protein ( Fig. 2A) . mSiah2 also markedly reduced levels of N-CoR amino acids 1-160 fused to Gal4 DBD, indicating that this effect did not require amino acids 161-2453 of N-CoR. The specificity of mSiah2 for N-CoR was demonstrated by its lack of effect on PPAR␥ ( Fig. 2A) . Similar results were obtained with cotransfections of N-CoR and Sina (data not shown). mSiah2-induced reduction in N-CoR levels was caused by increased degradation of N-CoR (Fig. 2B) . mSiah2 reduced the half-life of newly synthesized NCoR protein from ∼14 hr to ∼3 hr.
The amino terminus of mSiah2 was required for its ability to target N-CoR protein for degradation, as mSiah2⌬N did not lead to inhibition of N-CoR expression (Fig. 2C, lane 3) . This indicates an active role for a region of mSiah2 that is required for interacting with E2 ubiquitin conjugating enzymes (Tang et al. 1997) . The hypothesis that mSiah2 was targeting N-CoR for proteolytic degradation via a proteasomal pathway was supported by the observation that the proteasome inhibitor MG132 (Rock et al. 1994) abolished the ability of mSiah2 to reduce levels of N-CoR and Gal4-N-CoR(1-160) proteins (Fig. 2C ). This indicated that interaction with mSiah2 targeted N-CoR for degradation via a proteasomal pathway.
mSiah2 functions as an antirepressor for nuclear receptors
The ability of mSiah2 to reduce N-CoR protein levels by targeting N-CoR for degradation suggested that mSiah2 should block functional repression caused by N-CoR. RevErb provides an excellent means to test this hypothesis, as N-CoR is required for mediating RevErb repression in 293T cells (Zamir et al. 1997b ). Both mSiah2 and Sina nearly completely abolished the repression activity of RevErb in 293T cells (Fig. 3A) . In contrast, the inability of mSiah2⌬N to block RevErb activity was consistent with its inability to target NCoR for degradation (Fig. 3B ). Both Sina (Fig. 3C ) and mSiah2 (not shown) also blocked repression by Gal4-N-CoR(1-160). Sina had no significant effect on repression mediated by the amino terminal repression domain of SMRT (Fig. 3C ). This was expected, as the region of N-CoR that interacts with mSiah2/Sina is absent in fulllength, recombinant SMRT and neither mSiah2 nor Sina interacted with this protein (data not shown). In contrast to its ability to nearly completely abolish repression by RevErb, mSiah2 blocked TR repression by ∼50% (Fig. 3C ). This result is consistent with the N-CoR selectivity of RevErb, whereas TR may utilize other corepressor(s) as well.
If N-CoR degradation was the mechanism by which mSiah2 blocked repression, then MG132, which prevented the mSiah2-targeted proteasomal degradation of N-CoR, should also prevent mSiah2 from functioning as an antirepressor. The ability of mSiah2 to block the repressive activity of RevErb was prevented by treatment with MG132 (Fig. 3D ). The protease inhibitor had little or no effect on RevErb repression activity in the absence of mSiah2 transfection (Fig. 3D ), suggesting that in 293T cells there was little or no endogenous mSiah2-mediated proteasomal degradation of N-CoR in the absence of exogenous mSiah2. 
Proteolysis of N-CoR underlies cell specificity of repression
Previously, we observed that RevErb repression varies widely as a function of cell type (Harding and Lazar 1995) . Because RevErb utilizes N-CoR as corepressor, we hypothesized that mSiah2 expression could play a role in this cell-specific repression. mSiah2 mRNA is most abundant in cells of the nervous system that typically express two distinct mSiah2-related mRNAs (Della et al. 1993) . We found that 293T cells contained a single mSiah2 mRNA species, corresponding to the larger of the two reported species. In contrast, N18 cells contained more of this mSiah2 mRNA and, more strikingly, also contained the second mSiah2 mRNA (Fig. 4A) . Moreover, only the N18 neuroblastoma cells contained detectable levels of mSiah2 protein (Fig. 4B) . The N18 cells contained N-CoR mRNA at levels comparable to those in 293T cells (Fig. 4C) . However, consistent with the expression pattern of mSiah2, immunoblot analysis indicated that N-CoR protein was detectable in 293T cells but undetectable in N18 cells (Fig. 4D) .
The role of regulated N-CoR proteolysis in cell specificity of repression was examined by studying RevErb and TR repression activities in the N18 cells. Unlike non-neuronal 293T cells, and correlating with the expression of mSiah2, RevErb was minimally active in N18 cells (Fig. 5A) . Treatment with MG132 dramatically increased endogenous N-CoR protein levels in N18 cells (Fig. 5B) , consistent with the hypothesis that endogenous mSiah2 was targeting endogenous N-CoR for proteolytic degradation. Moreover, treatment with the proteasome inhibitor increased RevErb repression activity in N18 cells by >8-fold (from 1.9-to 16.2-fold, Fig. 5C ). Thus, the inability of RevErb to repress gene transcription in N18 cells was consistent with the expression of mSiah2 and the proteasome-dependent instability of N-CoR protein in these cells. In contrast to RevErb, Figure 5C shows that TR was better able to repress transcription in N18 cells (mean of 5.9-fold in two experiments). This is consistent with the ability of TR to utilize corepressors other than NCoR, such as SMRT. Nevertheless, proteolytic regulation played a modest role in TR repression, such that MG132 increased TR repression by ∼3-to 4-fold (mean of 3.4-fold in two experiments) in N18 cells.
The putative role of endogenous mSiah2 in this process suggested that expression of mSiah2⌬N, which interacts with N-CoR but lacks the ability to target it for degradation, might interfere with interaction between N-CoR and endogenous mSiah2, and thus allow RevErb to function as a repressor in N18 cells. Consistent with this hypothesis, mSiah2⌬N expression in N18 cells increased RevErb repression to about five fold over basal (Fig. 5D) . We note that this is not as dramatic as the effect of proteasomal inhibition. This could be because of insufficient expression of the mSiah2⌬N, but a more likely explanation is that although interference by mSiah2⌬N is competitive, interaction between endogenous mSiah2 and NCoR is likely to be noncompetitive, because the N-CoR is degraded in a short time frame.
The proteolytic mechanism underlying the function of mSiah2 as an antagonist of N-CoR provides a novel mode of regulating transcriptional repression in mammalian cells. Sina was shown recently to bind to a sequence-specific DNA-binding protein, Tramtrack, and target it for degradation through what appears to be a similar pathway (Li et al. 1997; Tang et al. 1997) . Sina function in Drosophila involves an additional protein, Phyllopod, which has no known mammalian homolog (Chang et al. 1995; Dickson et al. 1995) . Our results indicate that targeting of N-CoR degradation in mammalian cells by mSiah2 is either independent of such an activity or due to an endogenous Phyllopod-like activity. 
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Cold Spring Harbor Laboratory Press on September 6, 2017 -Published by genesdev.cshlp.org Downloaded from N-CoR and SMRT differ in their abilities to function with different nuclear receptors (Zamir et al. 1997b ). mSiah2-directed degradation of N-CoR provides a strategic mechanism for regulating repression in a receptor-specific manner. By preventing N-CoR accumulation, expression of mSiah2 may allow the specificity of SMRT or other putative nuclear receptor corepressors to dominate in a given cell type, such as the neuroblastoma cells. This regulatory mechanism may be even more general because N-CoR also functions as a corepressor for the transcription factor Mad (Alland et al. 1997; Hassig et al. 1997; Heinzel et al. 1997) and for the PLZF-RAR␣ oncoprotein (Grignani et al. 1998; Lin et al. 1998) . RevErb is a model for an N-CoR-selective nuclear receptor, and mSiah2 functions as a potent antirepressor in this context. In contrast, repression by TR is only modestly affected by the presence of ectopic or endogenous mSiah2 (in 293T and N18 cells, respectively) . This is consistent with the ability of TR to utilize other corepressors, most notably SMRT. Although recombinant SMRT was not degraded by mSiah2 (data not shown), we cannot rule out the possibility that endogenous SMRT is a target of mSiah2 and that some other molecule mediates the mSiah2-insensitive repression by TR. Importantly, whereas mSiah2-mediated corepressor proteolysis prevents a subset of repression complexes from forming, this does not prevent nuclear receptor heterodimers from binding to DNA, and the presence of mSiah2 has no effect upon the maximum transcriptional rate of TR in the presence of thyroid hormone (although the fold induction caused by hormone is reduced, as the baseline is not repressed; data not shown).
Cell specificity of transcriptional regulation has been demonstrated for a number of nuclear hormone receptors, as well as other transcription factors. In most cases, the mechanism of cell specificity is unknown. The present work strongly suggests that ubiquitin-mediated proteolysis of N-CoR is an important regulator of its function. It is tempting to speculate that similar regulation of coactivator protein levels might occur. Unlike N-CoR, mSiah2 is not ubiquitously expressed in differentiated mammalian cells, but rather is restricted primarily to cells of the nervous system. Multiple nuclear receptors that function as repressors are required for normal brain function and development (Forrest et al. 1996; Hamilton et al. 1996; Harding et al. 1997; Qiu et al. 1997) . Thus, regulation of N-CoR activity by targeted proteolysis is likely to modulate repression in important developmental and functional contexts.
Materials and methods
Two-hybrid screen
A yeast dihybrid screen of a 17-day mouse embryo library using NCoR(1-160) as bait was performed as described previously (Zamir et al. 1996) . The mSiah2 clone obtained multiple times in this screen was not obtained from the same library using at least 10 other baits (Zamir et al. 1996; Cheng et al. 1997) .
GST pulldown assays
Input proteins were translated in vitro and labeled with TNT kit (Promega). Preparation of GST fusion proteins and the protein interaction assays were performed as described previously (Zamir et al. 1997b) . Bound proteins were eluted by boiling in 30 µl of SDS-PAGE loading buffer, resolved by electrophoresis, and visualized by autoradiography. GST fusion proteins were stained with Coomassie blue to ensure equal loading.
Cell culture and transfection
Expression vectors for RevErb (Harding and Lazar 1993) , TR , and N-CoR (Horlein et al. 1995) have been described previously. The coding regions of Sina and mSiah2 cDNAs (Li et al. 1997) were amplified by PCR and subcloned into pCMX expression vector. Gal4 and GST fusion proteins were prepared by standard methods and sequenced. Experiments utilizing Gal4 fusion proteins used (Gal4 × 5)-SV40-luciferase reporter (Harding and Lazar 1995) except for the mammalian twohybrid experiment in which (Gal4 × 5)-E1B-luciferase was used. 293T and N18 cells were maintained in DMEM high glucose with 10% FCS and transfected with calcium phosphate as described previously or in some cases using Lipofectamine reagent (GIBCO) according to manufacturer's instructions. Luciferase activity was normalized to ␤-galactosidase activity, which served as an internal control for transfection efficiency. . (E) MG132 blocks mSiah2 effects on RevErb repression in 293T cells. mSiah2 inhibits RevErb repression in a concentration-dependent manner, and this is prevented by treatment with MG132.
Immunoprecipitation and pulse chase 293T cells were transfected with pCMX-Flag-N-CoR and pCMXmSiah2, and labeled for 3.5 hr with 35 S-Translabel (NEN) 16 hr later after which medium was changed and protein extracts were made at the indicated times and immunoprecipitated as described previously (Zamir et al. 1996) with anti-Flag antibody (Research Diagnostics).
Immunoblotting
Immunoblotting was performed as described previously (Xue et al. 1996) on 8-400 µg of total protein from 293T or N18 cells treated with or without 20 µM MG132, using antibodies to Gal4 DBD (Santa Cruz), Flag (Research Diagnostics), PPAR␥ (Xue et al. 1996) , and Sina (Li et al. 1997) , as described previously (Harding and Lazar 1995) . N-CoR polyclonal rabbit antiserum used for Western and coimmunoprecipitation (''␣-aminoterminal'') was raised against N-CoR amino acids 150-425 fused to GST. Carboxy-terminal N-CoR antibody used in coimmuniprecipitation was raised against amino acids 1944-2453 fused to GST. Neither the aminonor carboxy-terminal N-CoR antibodies immunoprecipitated in vitrotranslated SMRT (not shown). Rabbit antiserum was also raised against GST-mSiah2. For coimmunoprecipitation, subconfluent 293T cells (100-mm dish) were transfected with HA-mSiah2⌬N (20 µg). Coimmunoprecipitation was performed as described previously (Zamir et al. 1997a ).
Northern analysis Poly(A)
+ RNA was purified using the mini-oligo(dT) cellulose spin column (5 Prime-3 Prime, Boulder, CO). Northern analysis was performed as described previously (Zamir et al. 1997a) , with 2 µg of RNA for mSiah2 and 3.2 µg of RNA for N-CoR detection. 
